Glenmark Pharmaceuticals posts strong Q3 FY2025 earnings as global expansion gains momentum
Glenmark Pharmaceuticals Limited has reported a strong financial performance for the third quarter of fiscal year 2025, driven by significant growth in its India business ... Read More
Glenmark’s stunning Q1 performance: How the pharma powerhouse is dominating global markets
Glenmark Pharmaceuticals Limited (Glenmark) has announced impressive financial results for the first quarter of FY 2024-25, marked by a 6.9% increase in consolidated revenue and ... Read More
Glenmark Pharmaceuticals reports Q4 FY2023-24 revenue of Rs 30.63bn
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance ... Read More
Glenmark gets marketing approval for Ryaltris in 13 European countries
Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13 countries across the European Union (EU) and ... Read More